KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Share-based Compensation: 2009-2025

Historic Share-based Compensation for National Health Investors (NHI) over the last 15 years, with Jun 2025 value amounting to $1.1 million.

  • National Health Investors' Share-based Compensation rose 55.90% to $1.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.0 million, marking a year-over-year increase of 8.66%. This contributed to the annual value of $4.2 million for FY2024, which is 9.19% down from last year.
  • Per National Health Investors' latest filing, its Share-based Compensation stood at $1.1 million for Q2 2025, which was down 58.13% from $2.6 million recorded in Q1 2025.
  • In the past 5 years, National Health Investors' Share-based Compensation registered a high of $5.4 million during Q1 2021, and its lowest value of $670,000 during Q3 2024.
  • In the last 3 years, National Health Investors' Share-based Compensation had a median value of $865,500 in 2023 and averaged $1.2 million.
  • Per our database at Business Quant, National Health Investors' Share-based Compensation soared by 241.87% in 2021 and then crashed by 58.59% in 2023.
  • Quarterly analysis of 5 years shows National Health Investors' Share-based Compensation stood at $988,000 in 2021, then rose by 4.96% to $1.0 million in 2022, then declined by 16.59% to $865,000 in 2023, then decreased by 22.54% to $670,000 in 2024, then surged by 55.90% to $1.1 million in 2025.
  • Its Share-based Compensation stands at $1.1 million for Q2 2025, versus $2.6 million for Q1 2025 and $670,000 for Q4 2024.